Frey BM - Search Results

1

The 11-ketosteroid 11-ketodexamethasone is a glucocorticoid receptor agonist.

Rebuffat AG, Tam S, Nawrocki AR, Baker ME, Frey BM, Frey FJ, Odermatt A. Rebuffat AG, et al. Among authors: frey bm, frey fj. Mol Cell Endocrinol. 2004 Feb 12;214(1-2):27-37. doi: 10.1016/j.mce.2003.11.027. Mol Cell Endocrinol. 2004. PMID: 15062542

2

Gene delivery by a steroid-peptide nucleic acid conjugate.

Rebuffat AG, Nawrocki AR, Nielsen PE, Bernasconi AG, Bernal-Mendez E, Frey BM, Frey FJ. Rebuffat AG, et al. Among authors: frey bm, frey fj. FASEB J. 2002 Sep;16(11):1426-8. doi: 10.1096/fj.01-0706fje. Epub 2002 Jul 1. FASEB J. 2002. PMID: 12205036

3

A rapid screening assay for inhibitors of 11beta-hydroxysteroid dehydrogenases (11beta-HSD): flavanone selectively inhibits 11beta-HSD1 reductase activity.

Schweizer RA, Atanasov AG, Frey BM, Odermatt A. Schweizer RA, et al. Among authors: frey bm. Mol Cell Endocrinol. 2003 Dec 30;212(1-2):41-9. doi: 10.1016/j.mce.2003.09.027. Mol Cell Endocrinol. 2003. PMID: 14654249

4

Glucocorticoid-mediated mineralocorticoid receptor activation and hypertension.

Frey FJ, Odermatt A, Frey BM. Frey FJ, et al. Among authors: frey bm. Curr Opin Nephrol Hypertens. 2004 Jul;13(4):451-8. doi: 10.1097/01.mnh.0000133976.32559.b0. Curr Opin Nephrol Hypertens. 2004. PMID: 15199296 Review.

5

In vivo footprinting of the human 11beta-hydroxysteroid dehydrogenase type 2 promoter: evidence for cell-specific regulation by Sp1 and Sp3.

Nawrocki AR, Goldring CE, Kostadinova RM, Frey FJ, Frey BM. Nawrocki AR, et al. Among authors: frey bm, frey fj. J Biol Chem. 2002 Apr 26;277(17):14647-56. doi: 10.1074/jbc.M111549200. Epub 2002 Feb 15. J Biol Chem. 2002. PMID: 11850421 Free article.

6

Angiotensin II regulates 11beta-hydroxysteroid dehydrogenase type 2 via AT2 receptors.

Lanz B, Kadereit B, Ernst S, Shojaati K, Causevic M, Frey BM, Frey FJ, Mohaupt MG. Lanz B, et al. Among authors: frey bm, frey fj. Kidney Int. 2003 Sep;64(3):970-7. doi: 10.1046/j.1523-1755.2003.00192.x. Kidney Int. 2003. PMID: 12911547 Free article.

7

Epigenetic regulation of 11 beta-hydroxysteroid dehydrogenase type 2 expression.

Alikhani-Koopaei R, Fouladkou F, Frey FJ, Frey BM. Alikhani-Koopaei R, et al. Among authors: frey bm, frey fj. J Clin Invest. 2004 Oct;114(8):1146-57. doi: 10.1172/JCI21647. J Clin Invest. 2004. PMID: 15489962 Free PMC article.

8

Tumor necrosis factor alpha and phorbol 12-myristate-13-acetate down-regulate human 11beta-hydroxysteroid dehydrogenase type 2 through p50/p50 NF-kappaB homodimers and Egr-1.

Kostadinova RM, Nawrocki AR, Frey FJ, Frey BM. Kostadinova RM, et al. Among authors: frey bm, frey fj. FASEB J. 2005 Apr;19(6):650-2. doi: 10.1096/fj.04-2820fje. Epub 2005 Jan 19. FASEB J. 2005. PMID: 15659537

9

Tumor necrosis factor-alpha upregulates 11beta-hydroxysteroid dehydrogenase type 1 expression by CCAAT/enhancer binding protein-beta in HepG2 cells.

Ignatova ID, Kostadinova RM, Goldring CE, Nawrocki AR, Frey FJ, Frey BM. Ignatova ID, et al. Among authors: frey bm, frey fj. Am J Physiol Endocrinol Metab. 2009 Feb;296(2):E367-77. doi: 10.1152/ajpendo.90531.2008. Epub 2008 Dec 16. Am J Physiol Endocrinol Metab. 2009. PMID: 19088256 Free article.

10

Regulation of placental growth by aldosterone and cortisol.

Gennari-Moser C, Khankin EV, Schüller S, Escher G, Frey BM, Portmann CB, Baumann MU, Lehmann AD, Surbek D, Karumanchi SA, Frey FJ, Mohaupt MG. Gennari-Moser C, et al. Among authors: frey bm, frey fj. Endocrinology. 2011 Jan;152(1):263-71. doi: 10.1210/en.2010-0525. Epub 2010 Nov 10. Endocrinology. 2011. PMID: 21068161

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

235 results

Search Page